The American Psychiatric Association’s Guideline for Major Depressive Disorder: A Commentary

Authors

Lisa Cosgrove, University of Massachusetts BostonFollow
Allen F. Shaughnessy, Tufts University
Emily E. Wheeler, University of Massachusetts BostonFollow
Kirsten E. Austad, Harvard University
Irving Kirsch, Harvard University
Harold J. Bursztajn, Harvard University

Document Type

Article

Publication Date

3-17-2012

Abstract

The American Psychiatric Association (APA) published a new guideline for Major Depressive Disorder (MDD) which will undoubtedly be used by many practitioners to guide clinical decision-making. In fact, it is non-psychiatrist clinicians who prescribe the majority of antidepressants (AD). We review the APA’s most recent guideline on MDD and report on our observations.

Comments

This is a post-print, pre-published version of a letter to the editor that was published in Psychotherapy and Psychosomatics (2012), Volume 81, Pages 186–188: Editor was http://dx.doi.org/10.1159/000335523/.

Recommended Citation

Cosgrove L., Shaughnessy A.F., Wheeler E.E., Austad K.E., Kirsch I, Bursztajn H.J., "The American Psychiatric Association’s Guideline for Major Depressive Disorder: A Commentary," Psychotherapy and Psychosomatics (2012), Volume 81, Pages 186–188.

Publisher

Karger

Rights

© 2012 S. Karger AG, Basel